Authors

• Ivana Persico (ORCID: https://orcid.org/0000-0001-9946-1509)
• Marco Tucci (ORCID: https://orcid.org/0000-0003-4008-4897)
• Giuseppe Palmieri (ORCID: https://orcid.org/0000-0002-4350-2276)
• Maria Grazia Doro
• Mario Mandalà (ORCID: https://orcid.org/0000-0001-8846-8959)
• Maria Cristina Sini (ORCID: https://orcid.org/0000-0003-2796-6166)
• Laura Frogheri
• N. Viapiana (ORCID: https://orcid.org/0000-0003-4532-6621)
• Sara Simi (ORCID: https://orcid.org/0000-0001-6145-8275)
• Sara Baglivo (ORCID: https://orcid.org/0000-0002-4136-0577)
• Elisabetta Gambale (ORCID: https://orcid.org/0000-0001-6852-4562)
• Silvia Costabile
• Patrizia Leone
• Daniela Massi
• TWIN group and Italian Melanoma Intergroup (IMI)
• Chiara Quitadamo
• Vito Racanelli

Institutions

• University of Sassari (IT)
• University of Trento (IT)
• University of Perugia (IT)
• Ospedale Santa Chiara (IT)
• Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
• Ospedale Santa Maria (IT)
• Novartis (Italy) (IT)
• Cancer Genetics (United States) (US)
• University of Florence (IT)
• University of Bari Aldo Moro (IT)
• New York University (US)
• Misericordia University (US)

Publication Details

Journal

Journal of the European Academy of Dermatology and Venereology

Published

2026-09-04

DOI

https://doi.org/10.1111/jdv.70697

Primary Topic

Melanoma and MAPK Pathways

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Novartis Pharmaceuticals Corporation